| __timestamp | ACADIA Pharmaceuticals Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 34916000 |
| Thursday, January 1, 2015 | 90804000 | 36949000 |
| Friday, January 1, 2016 | 186456000 | 45240000 |
| Sunday, January 1, 2017 | 255062000 | 62416000 |
| Monday, January 1, 2018 | 265758000 | 81289000 |
| Tuesday, January 1, 2019 | 325638000 | 100359000 |
| Wednesday, January 1, 2020 | 388661000 | 105326000 |
| Friday, January 1, 2021 | 396028000 | 122356000 |
| Saturday, January 1, 2022 | 369090000 | 152848000 |
| Sunday, January 1, 2023 | 402466000 | 184259000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Corcept Therapeutics Incorporated and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Over this period, ACADIA Pharmaceuticals has consistently outpaced Corcept Therapeutics in SG&A spending, with a notable increase of approximately 1,130% from 2014 to 2023. In contrast, Corcept Therapeutics saw a more modest rise of around 428% in the same timeframe. This disparity highlights ACADIA's aggressive investment in administrative and sales functions, potentially reflecting a strategy focused on rapid market expansion. Meanwhile, Corcept's more conservative approach may indicate a focus on cost efficiency. These trends offer valuable insights into the strategic priorities of these companies as they navigate the evolving biopharma landscape.
argenx SE or Corcept Therapeutics Incorporated: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Alkermes plc
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights